Cardiovascular developments: patent highlights July to December 2006

Hermann A M Mucke1

  • 1HM Pharma Consultancy, Enelkelstrasse 28/32, A-1160 Wein, Austria. office@hmpharmacon.com

Current Opinion in Investigational Drugs (London, England : 2000)
|April 6, 2007
PubMed

Insights

This study validated patent trends in cardiovascular developments from the first half of 2006. Findings confirmed established patterns in pharmaceutical and biotechnology innovation for cardiovascular disorders.

Area of Science:

  • Cardiovascular Science
  • Intellectual Property Law
  • Pharmaceutical Industry

Background:

  • Cardiovascular disorders pose significant challenges to the pharmaceutical and biotechnology sectors.
  • Previous analysis identified key patent trends in cardiovascular developments from January to June 2006.

Purpose of the Study:

  • To validate the findings of a prior study on cardiovascular patent highlights.
  • To confirm if observed patterns represent established innovative efforts in the cardiovascular field.

Main Methods:

  • Replicated the search strategy used in the initial review.
  • Utilized Thomson Scientific's Investigational Drugs database.
  • Employed the same categorization for intellectual property disclosures.

Main Results:

  • The repeat analysis confirmed the patterns identified in the initial review.
  • Established modalities of innovative industry efforts in the cardiovascular field were validated.
  • The study provides a reliable overview of recent patent activity.

Conclusions:

  • The observed patent trends in cardiovascular developments are consistent and representative of industry innovation.
  • This validation strengthens the understanding of the intellectual property landscape in cardiovascular research.
  • The findings support ongoing research and development in the cardiovascular field.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Overview of the Cardiovascular System01:14

Overview of the Cardiovascular System

The cardiovascular system is a vital transportation system in the body. It comprises the heart and blood vessels and facilitates the exchange of gases, nutrients, and waste products.
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.